ClinicalTrials.govpublic full text
Panobinostat With Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma
diffuse large b cell lymphoma, dlbcl (diffuse large b cell lymphoma), panobinostat, lbh589 (panobinostat), lbh-589 (panobinostat), hdac inhibitor (histone deacetylase inhibitor), dac inhibitor (deacetylase inhibitor), deacetylase inhibitor, lymphoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 800269
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.